Cognex Corp
—- Market cap
- —
- Debt
- +-$673.05M
- Cash
- −$262.93M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CGNX stock price vs INCY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at INCY's multiple
Needs INCY P/E.
Implied fair value · at CGNX's multiple
Needs CGNX P/E.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CGNX FY 2025 (ended Dec 31, 2025) · INCY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
COGNEX CORP · implied price per share
Bear
$12.79
Base
$15.05
Bull
$17.30
INCYTE CORPORATION · implied price per share
Bear
-$7.58
Base
-$8.91
Bull
-$10.25
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.45x
3.83x
Net debt / EBITDA
Leverage against operating earnings
-4.38x
9.31x
Cash and equivalents
Liquid reserves on the balance sheet
$262.93M
$3.38B
Total debt
Interest-bearing obligations outstanding
-$673.05M
$19.78B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TELEDYNE TECHNOLOGIES INC
CGNX vs TDY
TERADYNE, INC
CGNX vs TER
ZEBRA TECHNOLOGIES CORP
CGNX vs ZBRA
METTLER TOLEDO INTERNATIONAL INC/
CGNX vs MTD
AMGEN INC
CGNX vs AMGN
GILEAD SCIENCES, INC.
CGNX vs GILD
VERTEX PHARMACEUTICALS INC / MA
CGNX vs VRTX
REGENERON PHARMACEUTICALS, INC.
CGNX vs REGN
BIOGEN INC.
CGNX vs BIIB
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.